Skip to main content

Devers Shannon L.'s Form 4 filing

Ionis Pharmaceuticals Inc (IONS) · filed Mar 5, 2026

Accession no.
0000874015-26-000135
Filed
Mar 5, 2026
Trade date
Mar 3, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.60M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Devers Shannon L.CIK 0002037721Officer (EVP, Chief Human Resources Ofc)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Common StockMOption exerciseAcquired+3,510$37.58+$131,905.826,051Direct
Mar 3, 2026Common StockMOption exerciseAcquired+3,760$40.85+$153,59629,811Direct
Mar 3, 2026Common StockMOption exerciseAcquired+5,500$34.69+$190,79535,311Direct
Mar 3, 2026Common StockMOption exerciseAcquired+6,951$32.60+$226,602.642,262Direct
Mar 3, 2026Common StockMOption exerciseAcquired+385$52.87+$20,354.9542,647Direct
Mar 3, 2026Common StockSSaleDisposed−14,321$79.12−$1,133,077.5228,326Direct
Mar 3, 2026Common StockSSaleDisposed−5,030$80.00−$402,40023,296Direct
Mar 3, 2026Common StockSSaleDisposed−755$80.84−$61,034.222,541Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2026Common StockMOption exerciseDisposed−6,951$0.00$0928Direct
Mar 3, 2026Common StockMOption exerciseDisposed−5,500$0.00$016,500Direct
Mar 3, 2026Common StockMOption exerciseDisposed−3,510$0.00$05,744Direct
Mar 3, 2026Common StockMOption exerciseDisposed−3,760$0.00$011,280Direct
Mar 3, 2026Common StockMOption exerciseDisposed−385$0.00$08,877Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)